iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week

Core Insights - Insight Molecular Diagnostics Inc. (iMDx) will report its third quarter 2025 financial results on November 10, 2025, after market close [1] - A live Zoom webinar will be held at 2:00 pm PT / 5:00 pm ET on the same day to discuss the financial results [1] - The company will also participate in the Stephens NASH25 Conference on November 19, 2025, in Nashville, TN [3] Company Overview - iMDx is a precision diagnostics technology company focused on democratizing access to molecular diagnostic testing to enhance patient outcomes [3] - The company employs a proprietary method to quantify dd-cfDNA, a key biomarker for transplant rejection [3] - iMDx relocated its headquarters from Irvine, California, to Nashville, Tennessee, in June 2025, and its NASDAQ symbol changed accordingly [4]